References
- Mcguire AL , PonderB, StefanssonK. Personalized genomic information: preparing for the future of genetic medicine. Nat. Rev. Genet.11(2) , 161–165 (2010).
- Lifton RP . Individual genomes on the horizon. N. Engl. J. Med.362(13) , 1235–1236 (2010).
- Samani NJ , TomaszewskiM, SchunkertH. The personal genome – the future of personalised medicine? Lancet375(9725) , 1497–1498 (2010).
- Lupski JR , ReidJG, Gonzaga-JaureguiC et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362(13) , 1181–1191 (2010).
- Worthey EA , MayerAN, SyversonGD et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 13(3) , 255–262 (2011).
- Tweardy DJ , BelmontJW. “Personalizing” academic medicine: opportunities and challenges in implementing genomic profiling. Transl. Res.154(6) , 288–294 (2009).
- Gahl WA , MarkelloTC, ToroC et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet. Med. 14(1) , 51–59 (2011).
- Prainsack B , ReardonJ, HindmarshR et al. Personal genomes: misdirected precaution. Nature 456(7218) , 34–35 (2008).
- Speicher MR , GeiglJB, TomlinsonIP. Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk. Lancet Oncol.11(9) , 890–898 (2010).
- Sharp RR . Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet. Med.13(3) , 191–194 (2011).
- Bloss CS , SchorkNJ, TopolEJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N. Engl. J. Med.364(6) , 524–534 (2011).
- McGowan ML , FishmanJR, LambrixMA. Personal genomics and individual identities: motivations and moral imperatives of early users. N. Genet. Soc.29(3) , 261–290 (2010).
- Mcguire AL , DiazCM, WangT, HilsenbeckSG. Social networkers‘ attitudes toward direct-to-consumer personal genome testing. Am. J. Bioethics9(6–7) , 3–10 (2009).
- Mayer AN , DimmockDP, ArcaMJ et al. A timely arrival for genomic medicine. Genet. Med. 13(3) , 195–196 (2011).
- Foster MW , SharpRR. Ethical issues in medical-sequencing research: implications of genotype-phenotype studies for individuals and populations. Hum. Mol. Genet.15(Spec. No. 1) , R45–R49 (2006).
- Merriam SB . Qualitative Research: A Guide to Design and Implementation. John Wiley&Sons, CA, USA (2009).
- Kuzel AJ . Sampling in qualitative inquiry. In: Doing Qualitative Research (2nd Edition). Crabtree BF, Miller WL (Eds). CA, USA, 33–45 (1999).
- Kondracki N , WellmanN, AmundsonD. Content analysis: review of methods and their applications in nutrition education. J. Nutr. Educ. Behav.34(4) , 224–230 (2002).
- Hruschka DJ , SchwartzD, St John DC et al. Reliability in coding open-ended data: lessons learned from HIV behavioral research. Field Methods16 , 3307–3331 (2004).
- McGuire AL , LupskiJR. Personal genome research: what should the participant be told? Trends Genet.26(5) , 199–201 (2010).
- Pagon RA , PinskyL, BeahlerCC. Online medical genetics resources: a US perspective. BMJ322(7293) , 1035–1037 (2001).
- Rahm AK , FeigelsonHS, WagnerN et al. Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J. Genet. Couns. 21(3) , 448–461 (2012).
- Gollust SE , GordonES, ZayacC et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 15(1) , 22–30 (2012).
- Deverka PA , SchullySD, IshibeN et al. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet. Med. 14(7) , 656–662 (2012).
- Green RC , BergJS, BerryGT et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet. Med. 14(4) , 405–410 (2012).
- Mcguire AL , BurkeW. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. J. Am. Med. Assoc.300(22) , 2669–2671 (2008).
- Gooding HC , LinnenbringerEL, BurackJ et al. Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk. Patient Educ. Couns. 64(1–3) , 259–267 (2006).
- Cassidy MR , RobertsJS, BirdTD et al. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer‘s disease. Alzheimers Dement. 4(6) , 406–413 (2008).
- Chao S , RobertsJS, MarteauTM et al. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Dis. Assoc. Disord. 22(1) , 94–97 (2008).
- Bunnik E , JanssensAC, SchermerM. How attitudes research contributes to overoptimistic expectations of personal genome testing. Am. J. Bioeth.9(6–7) , 23–25 (2009).
- McGowan ML , LambrixMM. Are social networkers and genome testers one in the same? The limitations of public opinion research for guiding clinical practice. Am. J. Bioethics9(6–7) , 21–23 (2009).
▪ Websites
- Intercensal Estimates of the Resident Population for Counties: April 1, 2000 to July 1, 2010. United States Census Bureau, Washington DC, USA (2011).www.census.gov/popest/data/intercensal/county/CO-EST00INT-01.html
- Educational Attainment 2005–2009: American Community Survey 5-year Estimates. United States Census Bureau, Washington DC, USA (2011).www.census.gov/acs/www/data_documentation/2009_release